Therapy
AltaRex Achieves Major Manufacturing Milestone for OvaRex MAb
Published in Cancer Weekly, January 29th, 2002
AltaRex Corp. (AXO.TO, ALXFF.OTC) announced that its contract manufacturer has successfully filled and lyophilized into vials the first lot of cell-culture-manufactured OvaRex antibody for use in the company's planned human pharmacokinetic study. As a result, the company expects in the near future to file an amendment to its Investigational New Drug submission for OvaRex MAb with the U.S. Food and Drug Administration (FDA) and to commence the trial roughly one month thereafter.
"This landmark milestone means that we now have our new cell-culture-manufactured OvaRex product available for the first time to take to the clinic for human comparability testing," noted...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2002-01-29)
More Articles from Cancer Weekly
- Acute Myeloid Leukemia
Mismatched Bone Marrow Grafts Feasible As Salvage Therapy - Oncology
Mutant Vaccinia Virus Attacks Tumor Targets, Ignores Resting Cells - Colon Cancer
Laparoscopic-Assisted Surgery Provides Minimal Benefits - Lung Cancer
Preventative Cranial Radiation Therapy Improves Quality Of Life - Prostate Cancer
Researchers Link Gene To Hereditary Form Of Disease - Skin Cancer
UAB Scientists Study Celecoxib's Effect On Skin Lesions - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
